In 2007, we first discussed the case of the amazing pricing of H P Acthar, a very old drug of questionable usefulness, as an example of the...
Showing posts with label health care prices. Show all posts
Showing posts with label health care prices. Show all posts
Oh, the Prices we Pay ... for Questionable Drug Marketing to Enrich Corporate Insiders - the Case of Questcor's H P Acthar Revisited
In 2007, we first discussed the case of the amazing pricing of H P Acthar, a very old drug of questionable usefulness, as an example of the...
More Tales of the Hospital CEO Compensation Bubble
The hospital CEO compensation bubble continues to grow. As the year draws to a close, I have found another set of stories about outsized pa...
Health Care Policy of the Insiders, by the Insiders, for the Insiders - the Newt Gingrich Case Files
Newt Gingrich's rise to the top of the pack of Republican contenders for the US presidency has earned him increased scrutiny. The resul...
Hospital Executives - What Will They Think of Next?
Health care organizations are now most often run by people with management, not clinical backgrounds. It seems like business schools have t...
RUCing About - Conflicts of Interest Affecting the Members of the RBRVS Update Committee
Since 2007, we have been writing about the secretive RUC (RBRVS Update Committee), the private AMA committee that somehow has managed to ge...
Abbott Laboratories Settles, Again
In 2007, we discussed a scheme that Abbott Laboratories seemed to be using to boost the price of Kaletra, a combination of two protease inh...
"Replace the RUC!"
We have frequently posted, first here in 2007 , and more recently here and here , about the little-known group that controls how the US Med...
